Thema: US58506Q1094
MEDP, US58506Q1094
iphone-5183942_1920.jpg - Foto: THN
Medpace Holdings stock trades at 606.20 euros in late quote
The latest Lang & Schwarz snapshot is dated October 29, 2026. It provides a dated reference point for investors following Medpace Holdings stock.
ad-hoc-news.de, heute 02:57 Uhr
MEDP, US58506Q1094
Medpace schedules October 21 results: what it means for ...
Mizuho kept Outperform on October 7, 2026. Medpace Holdings stock costs EUR 559.40 on October 20, 2026 at Lang & Schwarz after hours.
ad-hoc-news.de, 20.10.26 19:24 Uhr
MEDP, US58506Q1094
Mizuho lifts target to USD 700 for Medpace stock
Medpace reports results on October 21, 2026. Medpace stock costs USD 618.47 on October 16, 2026, down 1.61 percent versus Nasdaq's prior close.
ad-hoc-news.de, 17.10.26 21:58 Uhr
MEDP, US58506Q1094
Mizuho lifts target to USD 700 for Medpace stock
Medpace will report third-quarter results on October 21, 2026. Medpace stock costs EUR 561.60 on October 15, 2026 at 7:37 p.m. CEST.
ad-hoc-news.de, 15.10.26 19:44 Uhr
MEDP, US58506Q1094
Troendle sells Medpace stock. UBS sets a USD 673 target. ...
Second-quarter revenue reached USD 707.33 million, up 17.20 percent year over year. The average target for Medpace stock is USD 602.27.
ad-hoc-news.de, 07.10.26 05:07 Uhr
MEDP, US58506Q1094
Medpace stock heads into October 21 results after a 2.84 ...
Medpace stock was last at USD 602.90 on October 6, 2026, down 2.84 percent. Q2 revenue rose 17.2 percent to USD 707.3 million before October 21 results.
ad-hoc-news.de, 07.10.26 00:51 Uhr
MEDP, US58506Q1094
UBS sets USD 673 target for Medpace stock
Second-quarter revenue rose 17.20 percent to USD 707.33 million. Medpace stock costs EUR 557.60 on October 6, 2026 after EUR 552.90.
ad-hoc-news.de, 06.10.26 15:17 Uhr
MEDP, US58506Q1094
UBS sets USD 673 target for Medpace Holdings stock
Revenue reached USD 707.3 million in the second quarter of 2026. Medpace Holdings stock costs EUR 552.30 on October 5, 2026 after EUR 532.70.
ad-hoc-news.de, 05.10.26 20:54 Uhr
Medpace, Shares
Medpace Shares Present a Complex Investment Picture
